| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.25 | 6e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 4e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.077 | 0.2 |